Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Blood Advances|October 6, 2021
Follicular lymphoma subgroups with and without t(14;18) differ in their N-glycosylation pattern and IGHV usageEllen Leich, Claudia Maier, Riccardo Bomben, et al.
Leukemia & Lymphoma|April 7, 2010
Amplification at 11q23 targets protein kinase SIK2 in diffuse large B-cell lymphomaStefan Nagel, Ellen Leich, Hilmar Quentmeier, et al.
Plos Genetics|August 23, 2013
Characterization of the p53 cistrome--DNA binding cooperativity dissects p53's tumor suppressor functionsKatharina Schlereth, Charlotte Heyl, Anna-Maria Krampitz, et al.
British Journal of Haematology|December 19, 2014
The molecular spectrum and clinical impact of DIS3 mutations in multiple myelomaSusann Weißbach, Christian Langer, Bernhard Puppe, et al.
Cell Death & Disease|August 14, 2019
The NEDD8-activating enzyme inhibitor MLN4924 sensitizes a TNFR1+ subgroup of multiple myeloma cells for TNF-induced cell deathMohamed El-Mesery, Tina Rosenthal, Hilka Rauert-Wunderlich, et al.
Acta Pharmacologica Sinica|June 21, 2023
Cynaropicrin disrupts tubulin and c-Myc-related signaling and induces parthanatos-type cell death in multiple myelomaJoelle C Boulos, Ejlal A Omer, Daniela Rigano, et al.
Haematologica|June 11, 2011
Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profilesHeike Horn, Christopher Schmelter, Ellen Leich, et al.
Oncotarget|June 2, 2016
Rare SNPs in receptor tyrosine kinases are negative outcome predictors in multiple myelomaSarah Keppler, Susann Weiβbach, Christian Langer, et al.
Blood Cancer Journal|September 11, 2024
Association of ADAM family members with proliferation signaling and disease progression in multiple myelomaMarietheres Evers, Thorsten Stühmer, Martin Schreder, et al.
Pageof 5